Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Jan 27, 2023

SELL
$0.73 - $3.74 $0 - $3
-1 Reduced 0.01%
14,232 $44,000
Q3 2022

Oct 20, 2022

SELL
$0.73 - $3.74 $0 - $3
-1 Reduced 0.01%
14,232 $44,000
Q4 2021

Jan 27, 2023

SELL
$8.31 - $14.92 $2.33 Million - $4.19 Million
-280,516 Reduced 95.17%
14,233 $118,000
Q4 2021

Feb 11, 2022

SELL
$8.31 - $14.92 $2.33 Million - $4.19 Million
-280,516 Reduced 95.17%
14,233 $118,000
Q3 2021

Jan 27, 2023

BUY
$9.15 - $13.28 $2.57 Million - $3.73 Million
280,517 Added 1971.03%
294,749 $3.42 Million
Q3 2021

Nov 15, 2021

BUY
$9.15 - $13.28 $2.7 Million - $3.91 Million
294,749 New
294,749 $3.42 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $19B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.